Consider two numbers: 41 and 24.
That’s the difference researchers found in the number of population doublings stem cells from young versus older donors could undergo before reaching the end of their replicative capacity.
This isn’t a wellness claim or longevity marketing. It comes from a peer-reviewed study published in Bone in 2003—and it remains a striking illustration of something we now understand much better: our stem cells age with us.
Researchers at Aarhus University Hospital in Denmark isolated bone marrow stromal cells from two groups: young donors between 18 and 29, and older donors between 68 and 81.
Then, instead of simply comparing the cells at one moment in time, they kept them growing.
They divided and regrew the cultures generation after generation until the cells eventually reached senescence—the point at which they could no longer continue dividing.
The difference was significant.
Cells from younger donors reached roughly 41 population doublings, compared with just 24 in older donors. They also divided faster: approximately 0.09 population doublings per day versus 0.05 in the older group.
And it wasn’t only about quantity.
Markers of cellular senescence appeared earlier in cells from older donors, alongside a decline in their ability to differentiate into bone-forming cells.
Put simply: older stem cells didn’t just stop dividing sooner. They slowed down along the way.
That matters when we talk about the future of regenerative medicine.
Our cells at 30 and our cells at 70 are not necessarily equivalent starting material. Aging changes their biology, including characteristics that could matter for how useful those cells are in future applications.
And that’s part of the scientific rationale behind preserving cells earlier in life: you can’t go back at 70 and retrieve the cells you had at 30.
Of course, this particular study shouldn’t be treated as the final word. It included only 11 donors and studied cells expanded in a laboratory, not their behavior inside the human body. It was also published more than two decades ago, although subsequent research has continued to investigate—and support—the relationship between donor age and stem-cell function.
But I think the fundamental idea is worth paying attention to.
When we talk about longevity, we spend enormous amounts of time asking what we can do later to reverse the effects of aging.
Perhaps we should also be asking a different question:
What can we preserve today that may be much harder to replace tomorrow?
Source: Stenderup K, Justesen J, Clausen C, Kassem M. “Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells.” Bone. 2003;33(6):919–926.
